1408
M. Tabouazat et al.
LETTER
(16) Mori, N.; Ikeda, S.-I.; Sato, Y. J. Am. Chem. Soc. 1999, 121,
2722.
(17) Liard, A.; Quiclet-Sire, B.; Saicic, R. N.; Zard, S. Z.
Tetrahedron Lett. 1997, 38, 1759.
Acknowledgment
One of us (M.T.) thanks Région Rhône-Alpes for a doctoral fel-
lowship (MIRA program).
(18) (a) Cyrot, E.; Wiemann, J. Tetrahedron Lett. 1971, 12, 53.
(b) Cyrot, E. Ann. Chim. (Paris) 1971, 6, 413; Chem. Abstr.
1971, 77, 34182r.
References and Notes
(19) Rissafi, B.; El Louzy, A.; Loupy, A.; Petit, A.; Soufiaoui,
M.; Fkih-Tétouani, S. Eur. J. Org. Chem. 2002, 2518.
(20) For few reports on such carboannulation reactions giving
access to condensed structures, see: (a) Deady, L. W.;
Werden, D. M. J. Org. Chem. 1987, 52, 3930. (b) Radl, S.;
Kovarova, L. Collect. Czech. Chem. Commun. 1992, 57,
212.
(21) Tamura, Y.; Yoshima, Y.; Suzuki, M.; Terashima, M. Chem.
Ind. 1970, 1410.
(22) Kazarian, J.; Geribaldi, S.; Ferrero, L.; Rouillard, M.;
Azzaro, M. J. Org. Chem. 1978, 43, 1817.
(23) Typical Experimental Procedure (Table 1, entry 5) –
Synthesis of Diethyl 5,6,7,8-Tetrahydro-7,7-dimethyl-4-
hydroxy-5-oxo-1,3-naphthalenedicarboxylate (8a) and
Diethyl 5,6,7,8-Tetrahydro-7,7-dimethyl-5-oxo-1,3-
naphthalenedicarboxylate (9a)
(1) (a) Ishikawa, T.; Murota, M.; Watanabe, T.; Harayama, T.;
Ishi, H. Tetrahedron Lett. 1995, 36, 4269. (b) Konno, F.;
Ishikawa, T.; Kawahata, M.; Yamagushi, K. J. Org. Chem.
2006, 71, 9818.
(2) Talapatra, S. K.; Karmacharya, B.; De S, C.; Talapatra, B.
Phytochemistry 1988, 27, 3929.
(3) Wang, Y.-F.; Cao, J.-X.; Efferth, T.; Lai, G.-F.; Luo, S.-D.
Chem. Biodiversity 2006, 3, 646.
(4) Liu, L.; Li, A.-L.; Zhao, M. B.; Tu, P.-F. Chem. Biodiversity
2006, 4, 2932.
(5) Rukachaisirikul, V.; Sommart, U.; Phongpaichit, S.;
Hutadilok-Towatana, N.; Rungjindamal, N.; Sakayaroj, J.
Chem. Pharm. Bull. 2007, 55, 1316.
(6) Gu, W.; Ge, H. M.; Song, Y. C.; Ding, H.; Zhu, H. L.; Zhao,
X. A.; Tan, R. X. J. Nat. Prod. 2007, 70, 114.
(7) Shih, H.; Deng, L.; Carrera, C. J.; Adachi, S.; Cottam, H. B.;
Carson, D. A. Bioorg. Med. Chem. Lett. 2000, 10, 487.
(8) (a) Caro, Y.; Torrado, M.; Masaguer, C. F.; Raviña, E.;
Padin, F.; Brea, J.; Loza, M. I. Bioorg. Med. Chem. Lett.
2004, 14, 585. (b) Caro, Y.; Masaguer, C. F.; Raviña, E.
Tetrahedron: Asymmetry 2003, 34, 381.
(9) (a) Ghatak, A.; Dorsey, J. M.; Garner, C. M.; Pinney, K. G.
Tetrahedron Lett. 2003, 44, 4145. (b) Charrier, C.;
Bertrand, D.; Gesson, J.-P.; Roche, J. Bioorg. Med. Chem.
Lett. 2006, 16, 5339. (c) Chavan, S. P.; Rao, T. S.; Govande,
C. A.; Zubaidha, P. K.; Dhondge, V. D. Tetrahedron Lett.
1997, 38, 7633. (d) Tatsuta, K.; Kojima, N.; Chino, M.;
Kawazoe, S.; Nakata, M. Tetrahedron Lett. 1993, 34, 4961.
(e) Torrado, M.; Masaguer, C.; Ravina, E. Tetrahedron Lett.
2007, 48, 323.
(10) Chan, T. H.; Guertin, K. R.; Prasad, C. V. C.; Thomas,
A. W.; Strunz, G. M.; Salonius, A. Can. J. Chem. 1990, 68,
1170.
(11) (a) Liu, Z.; Cheng, Z.; Wang, C. CN 1,156,139, 2000; Appl.
CN 96,116,829; Chem. Abstr. 2000, 132, 12422w.
(b) Bueschken, W. DE 3,639,921, 1988; Chem. Abstr. 1988,
109, 151916y.
(12) (a) Johnson, W. S. Org. React. 1949, 2, 114.
(b) Schellhammer, C.-W.In Houben-Weyl Methoden der
Organischen Chemie, Vol. VII/2a; Müller, E., Ed.; Thieme:
Stuttgart, 1973, 143–144.
(13) (a) Danishefsky, S.; Harayama, T.; Singh, R. K. J. Am.
Chem. Soc. 1979, 101, 7008. (b) Faragher, R.; Gilgchrist,
T.; Southon, I. W. J. Chem. Soc., Perkin Trans. 1 1981,
2352. (c) Liu, H. J.; Ngooi, T. K.; Browne, E. N. C. Can. J.
Chem. 1988, 66, 3143. (d) Takeuchi, N.; Ohki, J.; Tobinaga,
S. Chem. Pharm. Bull. 1988, 36, 481.
Sodium hydride (50% oil, 48 mg, 1 mmol) was added to a
mixture of ester 7a (211 mg, 1 mmol), DMAP (12 mg, 0.1
mmol) and diethyl ethoxymethylenemalonate (433 mg, 2
mmol) stirred at 0 °C under nitrogen. The reaction mixture
immediately became yellow with release of hydrogen. After
stirring for 10 min at r.t., the mixture was heated at 180 °C
for 1 h. After cooling at r.t., the mixture was diluted with
CH2Cl2 and hydrolyzed with sat. aq NH4Cl. Workup gave an
oil which was purified by flash chromatography (SiO2, PE–
Et2O, 80:20) to afford a-tetralone 8a (50 mg, 15%) and
a-tetralone 9a (170 mg, 53%).
Compound 8a: mp 62–64 °C. TLC (SiO2, PE–Et2O, 50:50):
Rf = 0.39. IR (KBr film): 2950, 1717, 1701, 1635, 1605,
1443, 1228, 1208, 1191, 1150, 867, 774, 683 cm–1. 1H NMR
(300 MHz, CDCl3): d = 14.18 (s, 1 H, OH), 8.62 (s, 1 H, H-
2), 4.32 (q, 3J = 7.1 Hz, 4 H, 2 × OCH2CH3), 3.25 (s, 2 H,
H-8), 2.55 (s, 2 H, H-6), 1.38 (t, 3J = 7.1 Hz, 6H, 2 ×
OCH2CH3), 1.06 [s, 6 H, gem-(CH3)2]. 13C NMR (75.5 MHz,
CDCl3): d = 206.1 (C=O), 166.1 (OC=O), 166.0 (OC=O),
165.0 (C-4), 151.9 (C-8a), 141.4 (C-2), 120.7 (C-1), 117.9
(C-4a), 117.6 (C-3), 61.7 (OCH2CH3), 61.6 (OCH2CH3),
52.0 (C-6), 42.2 (C-8), 33.1 (C-7), 28.5 [gem-(CH3)2], 14.7
(OCH2CH3), 14.6 (OCH2CH3). ESI-HRMS: m/z calcd for
C18H22O6 [MNa+]: 357.1314; found: 357.1320.
Compound 9a: mp 78 °C. TLC (SiO2, PE–Et2O, 50:50):
Rf = 0.56. IR (KBr film): 2977, 2958, 2870, 1715, 1691,
1605, 1466, 1449, 1418, 1389, 1225, 1195, 1148, 1022, 755
cm–1. 1H NMR (300 MHz, CDCl3): d = 8.81 (d, 3J = 1.8 Hz,
1 H, H-4), 8.68 (d, 3J = 1.8 Hz, 1 H, H-2), 4.32 (q, 3J = 7.1
Hz, 4 H, 2 × OCH2CH3), 3.24 (s, 2 H, H-8), 2.54 (s, 2 H, H-
6), 1.42 (t, 3J = 7.1 Hz, 3 H, OCH2CH3), 1.40 (t, 3J = 7.1 Hz,
3 H, OCH2CH3), 1.07 [s, 6 H, gem-(CH3)2]. 13C NMR (75.5
MHz, CDCl3): d = 197.5 (C=O), 166.6 (OC=O), 166.5
(OC=O), 148.4 (C-8a), 136.3 (C-4a), 133.6 (C-2), 131.9
(C-4), 131.7 (C-1), 129.2 (C-3), 61.9 (2 × OCH2CH3), 52.0
(C-6), 42.0 (C-8), 33.3 (C-7), 29.0 [gem-(CH3)2], 14.7
(OCH2CH3), 14.6 (OCH2CH3). ESI-HRMS: m/z calcd for
C18H22O5 [MNa+]: 341.1359; found: 341.1357.
(14) Tarchompoo, B.; Thebtaranonth, C.; Thebtaranonth, Y.
Synthesis 1986, 785.
(15) (a) Brunet, J. J.; Essiz, M.; Caubère, P. Tetrahedron Lett.
1974, 15, 871. (b) Essiz, M.; Guillaumet, G.; Brunet, J. J.;
Caubère, P. J. Org. Chem. 1980, 45, 240.
Synlett 2009, No. 9, 1405–1408 © Thieme Stuttgart · New York